BridgeMD
New treatment option for Presbyopia
Official title Comparison of PRESBYOND Laser Blended Vision and Conventional Monovision LASIK in Individuals With Presbyopia: A Randomized Clinical Study
ClinicalTrials.gov ID: NCT07512089
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if laser blended vision (LBV) works better than traditional monovision LASIK to correct presbyopia in adults aged 40 to 55 years. Presbyopia is an age-related condition that makes it hard to see things up close.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 55
You may be able to join if
- Adults aged 40 to 55 years with presbyopia
- Suitable candidates for LASIK surgery based on clinical evaluation
- Stable refractive status for at least 1 year
- Best corrected distance visual acuity within normal range
- Willing and able to provide written informed consent
You likely can't join if
- Previous ocular surgery
- Corneal disease or abnormal corneal condition that may affect safety
- Significant ocular disease affecting visual function
- Severe dry eye or other ocular surface disorders
- Systemic disease that may affect study participation
- Inability to tolerate monovision or anisometropia
See the full eligibility criteria
- Adults aged 40 to 55 years with presbyopia
- Suitable candidates for LASIK surgery based on clinical evaluation
- Stable refractive status for at least 1 year
- Best corrected distance visual acuity within normal range
- Willing and able to provide written informed consent
- Willing to comply with study visits and follow-up
- Previous ocular surgery
- Corneal disease or abnormal corneal condition that may affect safety
- Significant ocular disease affecting visual function
- Severe dry eye or other ocular surface disorders
- Systemic disease that may affect study participation
- Inability to tolerate monovision or anisometropia
- Any condition that the investigator considers unsuitable for the study
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.